Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen MD, Rivet J, Moins-Teisserenc H, Ta VA, Ram-Wolff C, Bouaziz JD, Mahevas T, Bagot M, Mourah S, Louveau B, Sicre de Fontbrune F, Peffault de Latour R, de Masson A, Battesti G. Cohen E, et al. Among authors: louveau b. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e32-e34. doi: 10.1111/jdv.19408. Epub 2023 Aug 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37561935 No abstract available.
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.
Ranjbaryan M, Calvani J, Louveau B, Cuccuini W, Battesti G, Bozonnat A, Moins-Teisserenc H, Michonneau D, Bagot M, Ram-Wolff C, Dobos G, Mourah S, Battistella M, de Masson A. Ranjbaryan M, et al. Among authors: louveau b. Eur J Dermatol. 2023 Aug 1;33(4):439-440. doi: 10.1684/ejd.2023.4522. Eur J Dermatol. 2023. PMID: 37823502 No abstract available.
34 results